Vertigo, a common clinical symptom, often presents diagnostic and therapeutic challenges to healthcare professionals. This article aims to provide a comprehensive clinical approach to unraveling vertigo.
Vertigo is primarily a symptom of vestibular dysfunction. It can be peripheral, originating from the inner ear, or central, sourced from the brainstem or cerebellum. Conditions such as Benign Paroxysmal Positional Vertigo (BPPV), Meniere's disease, and vestibular neuritis are common peripheral causes. Central causes include migraines, multiple sclerosis, and cerebrovascular diseases.
An accurate history is crucial in diagnosing vertigo. The onset, duration, frequency, and associated symptoms can provide valuable clues. Physical examination should include a thorough neurological and otologic assessment. Special tests like the Dix-Hallpike maneuver or the HINTS (Head-Impulse, Nystagmus, Test of Skew) can be performed to differentiate between peripheral and central causes.
Management of vertigo is multifaceted and depends on the underlying cause. For BPPV, canalith repositioning maneuvers have proven effective. Vestibular suppressants can provide symptomatic relief but are not recommended for long-term use due to potential side effects. In refractory cases, vestibular rehabilitation therapy or surgical interventions may be considered.
While not routinely indicated, imaging studies like MRI or CT scan can be useful in cases where a central cause is suspected. Early identification of potentially serious conditions such as stroke or tumor is critical for guiding management.
In conclusion, vertigo requires a comprehensive clinical approach for accurate diagnosis and management. An understanding of the pathophysiology, thorough clinical assessment, appropriate use of imaging, and tailored management strategies are key to unraveling this complex symptom and improving patient outcomes.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation